Literature DB >> 26819835

Clotrimazole as a Cancer Drug: A Short Review.

S Kadavakollu1, C Stailey1, C S Kunapareddy1, S White1.   

Abstract

Although clotrimazole was first used against fungal infections, a body of research was later developed indicating that this drug has anticancer properties as well. The mechanism of action is based on the inhibition of mitochondrial-bound glycolytic enzymes and calmodulin, which starves cancer cells of energy. Clotrimazole and its derivatives have been shown to decrease rates of cancer cell proliferation, induce G1 phase arrest, and promote pro-apoptotic factors, which lead to cell death.

Entities:  

Keywords:  Calmodulin; Clotrimazole; Hexokinase; Human melanoma

Year:  2014        PMID: 26819835      PMCID: PMC4724869          DOI: 10.4172/2161-0444.1000219

Source DB:  PubMed          Journal:  Med Chem (Los Angeles)


  44 in total

1.  Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands.

Authors:  Mauro Ravera; Elisabetta Gabano; Manuele Sardi; Giuseppe Ermondi; Giulia Caron; Michael J McGlinchey; Helge Müller-Bunz; Elena Monti; Marzia B Gariboldi; Domenico Osella
Journal:  J Inorg Biochem       Date:  2010-12-14       Impact factor: 4.155

2.  [Synthesis and properties of clotrimazole and other antimycotic 1-triphenylmethylimidazoles].

Authors:  K H Büchel; W Draber; E Regel; M Plempel
Journal:  Arzneimittelforschung       Date:  1972-08

3.  Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole.

Authors:  Meiying Ning; Yingzhi Guo; Huaizhong Pan; Xianli Chen; Zhongwei Gu
Journal:  Drug Dev Ind Pharm       Date:  2005-05       Impact factor: 3.225

4.  Detachment of glycolytic enzymes from cytoskeleton of melanoma cells induced by calmodulin antagonists.

Authors:  L Glass-Marmor; R Beitner
Journal:  Eur J Pharmacol       Date:  1997-06-11       Impact factor: 4.432

5.  Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole.

Authors:  M Humayun Khalid; Yoshiharu Tokunaga; Anthony J Caputy; Eric Walters
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

6.  Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis.

Authors:  Jung Yun Chang; Yu-Kyoung Oh; Hak Soo Kong; Eun Jung Kim; Dong Deuk Jang; Ki Taek Nam; Chong-Kook Kim
Journal:  J Control Release       Date:  2002-07-18       Impact factor: 9.776

Review 7.  Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.

Authors:  Abdullah Yalcin; Sucheta Telang; Brian Clem; Jason Chesney
Journal:  Exp Mol Pathol       Date:  2009-01-14       Impact factor: 3.362

8.  Agonist-induced Ca2+ influx in human neutrophils is secondary to the emptying of intracellular calcium stores.

Authors:  M Montero; J Alvarez; J Garcia-Sancho
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

Review 9.  Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications.

Authors:  Heike Wulff; Aaron Kolski-Andreaco; Ananthakrishnan Sankaranarayanan; Jean-Marc Sabatier; Vikram Shakkottai
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  Analysis of the cytotoxic effects of ruthenium-ketoconazole and ruthenium-clotrimazole complexes on cancer cells.

Authors:  Elisa Robles-Escajeda; Alberto Martínez; Armando Varela-Ramirez; Roberto A Sánchez-Delgado; Renato J Aguilera
Journal:  Cell Biol Toxicol       Date:  2013-11-24       Impact factor: 6.691

View more
  9 in total

1.  Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor models.

Authors:  Andrew J McDonald; Katherine M Curt; Ruchi P Patel; Hanna Kozlowski; Dan L Sackett; Robert W Robey; Michael M Gottesman; Susan E Bates
Journal:  Exp Cell Res       Date:  2018-12-21       Impact factor: 3.905

2.  Protein aggregation and the evolution of stress resistance in clinical yeast.

Authors:  Yiwen R Chen; Inbal Ziv; Kavya Swaminathan; Joshua E Elias; Daniel F Jarosz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-04-19       Impact factor: 6.671

Review 3.  VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis.

Authors:  Andrea Magrì; Simona Reina; Vito De Pinto
Journal:  Front Chem       Date:  2018-04-06       Impact factor: 5.221

4.  A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase.

Authors:  Aldo Segura-Cabrera; Reshmi Tripathi; Xiaoyi Zhang; Lin Gui; Tsui-Fen Chou; Kakajan Komurov
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

5.  Imidazole Antifungal Drugs Inhibit the Cell Proliferation and Invasion of Human Breast Cancer Cells.

Authors:  Sung Hun Bae; Ju Ho Park; Hyeon Gyeom Choi; Hyesook Kim; So Hee Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-09-01       Impact factor: 4.634

6.  Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity.

Authors:  Zining Wang; Feifei Xu; Jie Hu; Hongxia Zhang; Lei Cui; Wenhua Lu; Wenzhuo He; Xiaojuan Wang; Mengyun Li; Huanling Zhang; Wenjing Xiong; Chunyuan Xie; Yongxiang Liu; Penghui Zhou; Jinyun Liu; Peng Huang; Xiaofeng Frank Qin; Xiaojun Xia
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

7.  Clotrimazole Inhibits HCC Migration and Invasion by Modulating the ERK-p65 Signaling Pathway.

Authors:  Xudong Liu; Jie Gao; Yaohui Sun; Feng Zhang; Wenzhi Guo; Shuijun Zhang
Journal:  Drug Des Devel Ther       Date:  2022-03-29       Impact factor: 4.162

8.  Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells.

Authors:  Thaís Oliveira; Douglas Lemos; Louise Jean; Jéssica M Kawashima; Vitória R de Azevedo; Eduardo J Salustiano; Vivian M Rumjanek; Robson Q Monteiro
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

9.  A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells.

Authors:  Manuela Cipolletti; Stefania Bartoloni; Claudia Busonero; Martina Parente; Stefano Leone; Filippo Acconcia
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.